09 jun: Berkshire Sells Unsecured ResCap Bonds
09 jun: Thousands Of AT&T Employees In Calif., Nevada Hold Walkou..
09-06-2012 00:07:00

UPDATE: J&J to Record $600 Million Charge Due to Outstanding Lawsuits

--J&J to take litigation charge of about $600 million in second quarter

--Charge deals with litigation surrounding drugs Risperdal, Invega and Natrecor

--Took $1.1 billion litigation charge in the fourth quarter of 2011

(Updated to include details of previous litigation charge in the third paragraph.)

By Ben Fox Rubin

Johnson & Johnson (JNJ) said it plans to record a special charge of roughly $600 million in its second quarter to increase its accrual for potential legal settlements, as it has faced a series of lawsuits over accusations of bribery and improper drug-marketing practices.

The company said the settlement payments stem for a series of outstanding civil cases that involve its drugs Risperdal, Invega and Natrecor, as well as nursing-home pharmacy operator Omnicare Inc. (OCR).

In the fourth quarter, J&J recorded a $1.1 billion charge related to litigation settlements. At the time, Chief Financial Officer Dominic Caruso said the litigation costs were primarily linked to Risperdal. The company didn't have a similar charge in its April first-quarter report.

The health-care products company has faced lawsuits related to alleged off-label promotion of its antipsychotic treatment Risperdal, which was once J&J's top-selling drug before generic copycats hit the market, as well as legal challenges over off-label promotion of another schizophrenia treatment, Invega, and the heart-failure drug Natrecor.

Furthermore, the federal government is suing J&J, accusing it of paying kickbacks to induce Omnicare to encourage use of Risperdal and other J&J drugs.

J&J also has dealt with state lawsuits regarding its promotion of Risperdal, including an Arkansas case in which the company in April was ordered to pay $1.2 billion after a jury found that J&J's past marketing of the drug violated the state's consumer-protection laws. J&J previously was ordered to pay $327 million in a South Carolina case and $258 million in Louisiana. The company is appealing all three cases.

In January, J&J agreed to settle a Texas case for $158 million.

Meanwhile, the company agreed to pay an $85 million fine in a criminal case regarding off-label marketing of Natrecor. Parallel civil litigation still hasn't been settled.

The company in April said its first-quarter earnings rose on a foreign-exchange-related gain tied to an acquisition and lower expenses.

Shares closed Friday at $62.98 and were unchanged after hours. The stock is down 4% so far this year.

--Anjali Athavaley contributed to this report.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

(END) Dow Jones Newswires

June 08, 2012 18:07 ET (22:07 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 aug
VWS
Til Euroinvestor administrator! Jeg må forlange at Administrator forbyder pjneumann at deltage i deb..
109
27 aug
 
I gamle dage, var der et sted hvor man kunne aflevere disse ønsker, men jeg ved ikke hvor det er nu,..
58
30 aug
VWS
  London baseret analytiker Pinaki Das fra Bank of America Merrill Lynch fik i denne uge skabt en st..
49
31 aug
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
43
26 aug
VWS
Skal vi ikke alle stoppe denne interne hån! Ingen kan lide at tabe penge, skulle vi ikke istedet giv..
40
01 sep
OGZPY
Jeg vil gerne update forum om hvad der sker og hvad det kan medføre - Jeg befinder mig midt i Ukrain..
25
26 aug
VWS
Det er geni-streg Bank of America i dag har lavet. De har fundet to argumenter til at skabe frygt på..
17
27 aug
VWS
Hej kanonkaj   Er enig i, at der skal holdes en ordentlig tone... Men hvad synes du om ordlyden af o..
16
28 aug
VWS
Et godt råd er ikke at overlade dine investeringer til anonyme "rådgivere" fra et forum som i den gr..
15
30 aug
I:SP500
Jeg vil mene at vi er et sted imellem Relief og Optimism.   Med hensyn til dine punkter: All time h..
13

Euroinvestor.com A/S løfter omsætningen og indtjeningen markant.

29-08-2014 10:55:42
Delårsrapport 2014 for Euroinvestor.com A/S Fondsbørsmeddelelse nr. 11. 2014  29. august 2014 Resumé: Delårsrapport 2014 ..

Aktier/tendens: Regnskaber, nøgletal og Rusland/Ukraine i fokus

29-08-2014 08:30:15
Det tegner til en flad til let positiv udvikling for de danske aktier, når markedet åbner fredag kl. 9:00. Futures på de store europæiske børser peger i hvert f..

Vestas: Energiagentur advarer om afmatning

28-08-2014 16:00:21
Usikkerhed om politiske rammebetingelser truer med at dæmpe momentum for investering i vedvarende energiprojekter, konkluderer det internationale energiagentur,..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/åbning: Brøndby IF hamrer i vejret
2
Rekordmange danskere flyver fra Hamborg - avis
3
Aktier/Nordea: Venter stigninger i ellers værste aktiemåned
4
Ukraine trækker sig fra kamp i lufthavn
5
Vestas-kunde får grønt lys til nyt mølleprojekt i Halland
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
2. september 2014 03:58:49
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140825.1 - EUROWEB7 - 2014-09-02 03:58:49 - 2014-09-02 03:58:49 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x